Literature DB >> 9916119

rfb mutations in Vibrio cholerae do not affect surface production of toxin-coregulated pili but still inhibit intestinal colonization.

S L Chiang1, J J Mekalanos.   

Abstract

The toxin-coregulated pilus (TCP) of Vibrio cholerae is essential for colonization. It was recently reported that rfb mutations in V. cholerae 569B cause the translocation arrest of the structural subunit of TCP, raising the possibility that the colonization defects of lipopolysaccharide mutants are due to effects on TCP biogenesis. However, an rfbB gene disruption in either V. cholerae O395 or 569B has no apparent effect on surface TCP production as assessed by immunoelectron microscopy and CTX phage transduction, and an rfbD::Tn5lac mutant of O395 also shows no defect in TCP expression. We conclude that the colonization defect associated with rfb mutations is unrelated to defects in TCP assembly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916119      PMCID: PMC96415     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

Review 1.  Salmonella O antigens and virulence.

Authors:  R J Roantree
Journal:  Annu Rev Microbiol       Date:  1967       Impact factor: 15.500

2.  A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.

Authors:  V L Miller; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

3.  The role of the flagellum in the adherence of Vibrio cholerae.

Authors:  S R Attridge; D Rowley
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

4.  Mapping of chromosomal loci associated with lipopolysaccharide synthesis and serotype specificity in Vibrio cholerae 01 by transposon mutagenesis using Tn5 and Tn2680.

Authors:  H M Ward; P A Manning
Journal:  Mol Gen Genet       Date:  1989-08

5.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.

Authors:  R K Taylor; V L Miller; D B Furlong; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Serotype conversion in Vibrio cholerae O1.

Authors:  U H Stroeher; L E Karageorgos; R Morona; P A Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  The specificity of Vibrio cholerae adherence and the significance of the slime agglutinin as a second mediator of in vitro attachment.

Authors:  S R Attridge; D Rowley
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

8.  Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells.

Authors:  V S Baselski; C D Parker
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

9.  Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter.

Authors:  V L Miller; V J DiRita; J J Mekalanos
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

10.  Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

Authors:  D A Herrington; R H Hall; G Losonsky; J J Mekalanos; R K Taylor; M M Levine
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  20 in total

1.  A role for lipopolysaccharide in turkey tracheal colonization by Bordetella avium as demonstrated in vivo and in vitro.

Authors:  P A Spears; L M Temple; P E Orndorff
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  Selection of available suicide vectors for gene mutagenesis using chiA (a chitinase encoding gene) as a new reporter and primary functional analysis of chiA in Lysobacter enzymogenes strain OH11.

Authors:  Guoliang Qian; Yansheng Wang; Dongyu Qian; Jiaqin Fan; Baishi Hu; Fengquan Liu
Journal:  World J Microbiol Biotechnol       Date:  2011-07-17       Impact factor: 3.312

3.  Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host.

Authors:  Yang Fu; Matthew K Waldor; John J Mekalanos
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

4.  Flagellum-independent surface migration of Vibrio cholerae and Escherichia coli.

Authors:  I I Brown; C C Häse
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

5.  Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation.

Authors:  J Nesper; C M Lauriano; K E Klose; D Kapfhammer; A Kraiss; J Reidl
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Biology, Mechanism, and Structure of Enzymes in the α-d-Phosphohexomutase Superfamily.

Authors:  Kyle M Stiers; Andrew G Muenks; Lesa J Beamer
Journal:  Adv Protein Chem Struct Biol       Date:  2017-05-17       Impact factor: 3.507

7.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.

Authors:  Gi-eun Rhie; Hae-Mi Jung; Bong Su Kim; John J Mekalanos
Journal:  Vaccine       Date:  2008-06-26       Impact factor: 3.641

9.  Facile method for site-specific gene integration in Lysobacter enzymogenes for yield improvement of the anti-MRSA antibiotics WAP-8294A and the antifungal antibiotic HSAF.

Authors:  Yan Wang; Guoliang Qian; Fengquan Liu; Yue-Zhong Li; Yuemao Shen; Liangcheng Du
Journal:  ACS Synth Biol       Date:  2013-08-27       Impact factor: 5.110

10.  Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins.

Authors:  Verena Olivier; Jessica Queen; Karla J F Satchell
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.